Your session is about to expire
← Back to Search
Texture Changing Coatings for Low Vision and Blindness
N/A
Waitlist Available
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Participants should be blind or visually impaired for greater than 10 years, either congenitally or acquired
Must not have
Participants with amputations or outer extremity conditions affecting hand use will be excluded.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
No Placebo-Only Group
Summary
"This trial proposes a new no-power testing platform that allows people with low vision or blindness to receive test results through a texture change that they can feel by touch. This technology aims to promote independence and privacy
Who is the study for?
This trial is for individuals with low vision or blindness. Participants will interact with a mock COVID-19 rapid antigen test designed to report results through texture change, which can be detected by touch.
What is being tested?
The study tests a new type of at-home COVID-19 rapid test that doesn't require sight. It uses texture changes to convey results, aiming to make testing accessible and private for people with visual impairments.
What are the potential side effects?
Since this trial involves interaction with non-invasive materials and does not include medication or injections, there are no direct medical side effects expected from participating in the study.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been blind or visually impaired for over 10 years.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have any amputations or conditions that affect my hand use.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
General feedback
Response time of each trial of a participant identifying whether the model test is positive or negative
Success rate of identifying whether the model test is positive or negative
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Interaction with Coated SurfacesExperimental Treatment3 Interventions
Participants in this arm will interact with the device and surface coated with the polymer-antibody coating. Subjects will be trained with a "positive" test and "negative" test prior to device testing. Subjects will then administer the synthetic saliva themselves and asked to determine if there was COVID antigen in the saliva by touching the device to compare the test patch to the positive and negative control patches. Subjects will also rate device usability.
Find a Location
Who is running the clinical trial?
University of DelawareLead Sponsor
161 Previous Clinical Trials
25,572 Total Patients Enrolled